AI (artificial intelligence) is rapidly gaining traction in mental health care, and for good reason. It offers the potential to streamline care, uncover clinical insights, and broaden access to ...

In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated.

This promising outlook positions AI as a powerful tool in addressing global mental health crises. However, a recent report from Spring Health highlights a significant and often overlooked risk for HR ...

Ketamine's rapid antidepressant effects have led to a significant increase in off-label psychiatric use, despite the lack of ...

Off-label prescription of psychiatric drugs in the United States began to take off in the 1990s. Children and adolescents are ...

Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...

A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...